» Articles » PMID: 23850550

Stem Cell Origin of Testicular Seminoma

Overview
Publisher Elsevier
Specialties Oncology
Urology
Date 2013 Jul 16
PMID 23850550
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: A major question concerning cancer is its cells of origin. We hypothesized that distinct cancer subtypes arise from unique cancer-initiating cells. By performing a microarray meta-analysis of seminomas and spermatogonial stem cells, we investigated a putative cell of origin for seminoma.

Materials And Methods: We obtained published microarray data for 6 human adult germ cell lines, 16 embryonic stem cell lines, 3 normal testicular tissue samples, and 40 seminomas from the Gene Expression Omnibus database. By assessing correlations between various tissue microarrays, we determined the number of transitional events and the distance between seminomas and human spermatogonial stem cells.

Results: Our meta-analysis showed that spermatogonial stem cells correlated similarly with seminoma (95% CI of Spearman ρ, 0.33-0.44) and with normal somatic testicular tissue cells (95% CI, 0.39-0.40), which suggests parallel paths of cellular origins.

Conclusion: Analysis of our results suggests that a unique cancer subtype, namely seminoma, may have originated from an undifferentiated cell with stemness features rather than from a differentiated cell that acquired stemness features.

Citing Articles

Pan-Cancer Analysis Identifies and Associated Antisense Transcripts as Biomarkers for Cancer.

Ragusa D, Tosi S, Sisu C Cells. 2022; 11(22).

PMID: 36429006 PMC: 9688723. DOI: 10.3390/cells11223577.


Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis.

Medvedev K, Savelyeva A, Chen K, Bagrodia A, Jia L, Grishin N Cancer Inform. 2022; 21:11769351221132634.

PMID: 36330202 PMC: 9623390. DOI: 10.1177/11769351221132634.


A Novel Tissue and Stem Cell Specific TERF1 Splice Variant Is Downregulated in Tumour Cells.

Morcos Y, Najjar G, Meessen S, Witt B, Azoitei A, Kumar M Int J Mol Sci. 2019; 21(1).

PMID: 31877678 PMC: 6981981. DOI: 10.3390/ijms21010085.


Personalised cancer care: promises and challenges of targeted therapy.

Tu S, Bilen M, Tannir N J R Soc Med. 2016; 109(3):98-105.

PMID: 26933155 PMC: 4794967. DOI: 10.1177/0141076816631154.


The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele.

Shetzer Y, Kagan S, Koifman G, Sarig R, Kogan-Sakin I, Charni M Cell Death Differ. 2014; 21(9):1419-31.

PMID: 24832469 PMC: 4131174. DOI: 10.1038/cdd.2014.57.


References
1.
Rajpert-De Meyts E, Kvist M, Skakkebaek N . Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance. Virchows Arch. 1996; 428(3):133-9. DOI: 10.1007/BF00200655. View

2.
Irish J . The mean measure of divergence: its utility in model-free and model-bound analyses relative to the Mahalanobis D(2) distance for nonmetric traits. Am J Hum Biol. 2009; 22(3):378-95. DOI: 10.1002/ajhb.21010. View

3.
Goldstein D, Ruiz Linares A, Cavalli-Sforza L, Feldman M . An evaluation of genetic distances for use with microsatellite loci. Genetics. 1995; 139(1):463-71. PMC: 1206344. DOI: 10.1093/genetics/139.1.463. View

4.
Toyooka Y, Tsunekawa N, Akasu R, Noce T . Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci U S A. 2003; 100(20):11457-62. PMC: 208779. DOI: 10.1073/pnas.1932826100. View

5.
Pierce G, ABELL M . Embryonal carcinoma of the testis. Pathol Annu. 1970; 5:27-60. View